Jean Bauer

2.3k total citations
52 papers, 1.8k citations indexed

About

Jean Bauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jean Bauer has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Jean Bauer's work include Cancer Treatment and Pharmacology (15 papers), Cancer Genomics and Diagnostics (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Jean Bauer is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Cancer Genomics and Diagnostics (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Jean Bauer collaborates with scholars based in Switzerland, Italy and Germany. Jean Bauer's co-authors include Cristiana Sessa, Serge Leyvraz, Jürg Bernhard, Richard Herrmann, Gabriela Kornek, Walter Mingrone, Keith B. Glaser, Bengt Glimelius, Piercarlo Saletti and Thomas Ruhstaller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jean Bauer

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Bauer Switzerland 22 1.2k 582 447 378 231 52 1.8k
Aristidis Polyzos Greece 24 1.3k 1.1× 481 0.8× 366 0.8× 718 1.9× 197 0.9× 67 2.4k
G. Deplanque France 23 1.3k 1.1× 812 1.4× 542 1.2× 633 1.7× 132 0.6× 77 2.3k
Don V. Jackson United States 27 1.3k 1.1× 508 0.9× 270 0.6× 337 0.9× 251 1.1× 75 2.0k
Reinhard von Roemeling United States 23 728 0.6× 626 1.1× 606 1.4× 774 2.0× 100 0.4× 72 2.0k
Kristi A. Boehm United States 24 1.5k 1.2× 736 1.3× 720 1.6× 495 1.3× 102 0.4× 77 2.3k
G. Frasci Italy 22 1.3k 1.1× 976 1.7× 315 0.7× 400 1.1× 127 0.5× 97 1.9k
Florian Hohla Austria 23 1.0k 0.9× 411 0.7× 330 0.7× 349 0.9× 592 2.6× 41 1.8k
Karl‐Heinz Thierauch Germany 19 908 0.8× 502 0.9× 409 0.9× 1.0k 2.7× 118 0.5× 33 2.5k
Gregory D. Leonard United States 13 1.4k 1.2× 235 0.4× 286 0.6× 517 1.4× 173 0.7× 30 2.0k
Felix E. de Jongh Netherlands 22 1.2k 1.1× 448 0.8× 385 0.9× 250 0.7× 355 1.5× 34 2.1k

Countries citing papers authored by Jean Bauer

Since Specialization
Citations

This map shows the geographic impact of Jean Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Bauer more than expected).

Fields of papers citing papers by Jean Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Bauer. The network helps show where Jean Bauer may publish in the future.

Co-authorship network of co-authors of Jean Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Bauer. A scholar is included among the top collaborators of Jean Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Bauer. Jean Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallerani, Elisa, Jean Bauer, Dagmar Hess, et al.. (2010). A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies. Acta Oncologica. 50(7). 1105–1110. 11 indexed citations
2.
Bauer, Jean, et al.. (2009). Bellini Duct Carcinoma. Clinical Nuclear Medicine. 34(8). 541–542. 1 indexed citations
3.
Voelter, Verena, A. Zouhair, Henri Vuilleumier, et al.. (2006). CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II. British Journal of Cancer. 95(6). 710–716. 18 indexed citations
4.
Jermann, Monika, Rolf A. Stahel, Marc Salzberg, et al.. (2005). A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. Cancer Chemotherapy and Pharmacology. 57(4). 533–539. 44 indexed citations
5.
6.
Lamy, Olivier, et al.. (2004). Acquired hemophilia as first manifestation of breast carcinoma in a man under long-term spironolactone therapy. International Journal of Clinical Oncology. 9(2). 130–133. 8 indexed citations
7.
Sessa, Cristiana, C. Cuvier, S. Caldiera, et al.. (2002). Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors. Annals of Oncology. 13(7). 1140–1150. 37 indexed citations
8.
Stupp, Roger, Alexandre Bodmer, B Duvoisin, et al.. (2001). Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/II Trial with Topotecan and Vinorelbine. Oncology. 61(Suppl. 1). 35–41. 10 indexed citations
9.
Özşahin, Mahmut, et al.. (2001). Invasive bladder carcinoma: A pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin. International Journal of Cancer. 96(6). 350–355. 16 indexed citations
10.
Sessa, Cristiana, Carla Minoia, A. Ronchi, et al.. (1998). Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Annals of Oncology. 9(12). 1315–1322. 45 indexed citations
11.
Marzolini, Catia, Fei Shen, Jean Bauer, et al.. (1998). Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration. Cancer Chemotherapy and Pharmacology. 42(6). 433–440. 60 indexed citations
12.
Stupp, Roger, Jean Bauer, Olivia Pagani, et al.. (1998). Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial. Annals of Oncology. 9(11). 1233–1242. 21 indexed citations
13.
Pyrhönen, Seppo, Ritva Valavaara, Hans Modig, et al.. (1997). Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study. British Journal of Cancer. 76(2). 270–277. 80 indexed citations
14.
Glaser, Keith B., et al.. (1995). Cellular and Topical in vivo Inflammatory Murine Models in the Evaluation of Inhibitors of Phospholipase A<sub>2</sub>. Skin Pharmacology and Physiology. 8(6). 300–308. 15 indexed citations
15.
Michel, G, Serge Leyvraz, Jean Bauer, et al.. (1994). Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer. Annals of Oncology. 5(4). 369–370. 15 indexed citations
16.
Glaser, Keith B., Richard P. Carlson, Anita Sung, et al.. (1993). Pharmacological characterization of WAY-121,520: A potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). Inflammation Research. 39(S1). C30–C32. 6 indexed citations
17.
Glaser, Keith B., Amy Sung, Jean Bauer, & Barry M. Weichman. (1993). Regulation of eicosanoid biosynthesis in the macrophage. Biochemical Pharmacology. 45(3). 711–721. 90 indexed citations
18.
Delaloye, Jean-François, et al.. (1993). Intraperitoneal Carboplatin in Advanced Ovarian Carcinoma. Gyn�kologisch-geburtshilfliche Rundschau. 33(1). 25–30.
19.
Leyvraz, Serge, U Hess, Gérard Flesch, et al.. (1992). Pharmacokinetics of Pamidronate in Patients With Bone Metastases. JNCI Journal of the National Cancer Institute. 84(10). 788–792. 60 indexed citations
20.
Bauer, Jean, et al.. (1989). Cutaneous 10 MHz ultrasound B scan allows the quantitative assessment of burn depth. Burns. 15(1). 49–51. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aristidis Polyzos Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Don V. Jackson Breakdown of academic impact, for papers by Reinhard von Roemeling Breakdown of academic impact, for papers by Kristi A. Boehm Breakdown of academic impact, for papers by G. Frasci Breakdown of academic impact, for papers by Florian Hohla Breakdown of academic impact, for papers by Karl‐Heinz Thierauch Breakdown of academic impact, for papers by Gregory D. Leonard Breakdown of academic impact, for papers by Felix E. de Jongh
Rankless by CCL
2026